Danaher Corporation (NYSE:DHR) will begin trading ex-dividend on December 24, 2020. The quarterly dividend payment of $ 0.18 per share is scheduled to be paid on January 29, 2021. The dividend yield based on the latest trading day closing price was 0.32 percent. Shareholders who purchased DHR shares prior to the ex-dividend date are eligible for the cash dividend payment.
|Date||Symbol||Company Name||Period||Value||Record Date||Payment Date||Exchange Date||displaynhide||day_navigation||week_navigation||month_navigation||Link||div_value|
Danaher Corporation recently reported third quarter financial results on October 22, 2020, before market open, the Washington based company unveiled income for the third quarter of $ 1.72 per share, from the revenue of $ 5,883.00 million. The quarterly earnings enlarged 48.28 percent while revenues surged 16.80 percent compared with the same quarter last year.
Street analysts expected Danaher Corporation recently reported third quarter financial results on October 22, 2020, before market open, the Washington based company to report income of $ 1.36 per share on revenue of $ 5513.83 million for the third quarter. The bottom line results beat street analysts by $ 0.36 or 26.47 percent, at the same time, top line results outshined analysts by $ 369.17 million or 6.70 percent.
Shares of Danaher Corporation traded low $ -3.23 or -1.43 percent on Tuesday, reaching $ 222.93 with volume of 1.82 million shares. Danaher Corporation has traded high as $ 226.07 and has cracked $ 222.64 on the downward trend
According to the previous trading day, closing price of $ 222.93, representing a 89.10 % increase from the 52 week low of $ 119.60 and a 8.92 % decrease over the 52 week high of $ 248.32.
The company has a market capital of $ 158.36 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The companys Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.